Credit Suisse Ag Nova Bay Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 12, 2019	SELL	$0.45 - $1.73 $9,230 - $35,485	-20,512 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.28 - $3.1 $5,743 - $63,587	20,512 New	20,512 $35,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $42.2M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.